| # | Drug | Count |
|---|---|---|
| 0 | GLATIRAMER ACETATE | 827 |
| 1 | ERGOCALCIFEROL | 57 |
| 2 | GABAPENTIN | 18 |
| 3 | BACLOFEN | 17 |
| 4 | FREMANEZUMAB-VFRM | 17 |
| 5 | GOLIMUMAB | 17 |
| 6 | ALBUTEROL SULFATE | 15 |
| 7 | GLATIRAMER | 14 |
| 8 | LEVOTHYROXINE SODIUM | 14 |
| 9 | CETIRIZINE HYDROCHLORIDE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLATIRAMER ACETATE | 827 | 0.0139 |
| 1 | ALOGLIPTIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0071 |
| 2 | HYDROCORTISONE VALERATE | 4 | 0.0064 |
| 3 | FLUORESCEIN | 3 | 0.0048 |
| 4 | ONTRUZANT | 2 | 0.0038 |
| 5 | FLUORESCEIN SODIUM | 1 | 0.0032 |
| 6 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | 1 | 0.0029 |
| 7 | FERUMOXYTOL | 5 | 0.0026 |
| 8 | BACTERIOSTATIC WATER | 1 | 0.0024 |
| 9 | GLATIRAMER ACETATE INJECTION | 11 | 0.0023 |
| # | Drug class | Count |
|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 57 |
| 1 | Corticosteroid [EPC] | 24 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 24 |
| 3 | Benzodiazepine [EPC] | 19 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 18 |
| 5 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 17 |
| 6 | Vitamin C [EPC] | 14 |
| 7 | Proton Pump Inhibitor [EPC] | 12 |
| 8 | Platinum-based Drug [EPC] | 11 |
| 9 | Anti-IgE [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Diagnostic Dye [EPC] | 3 | 0.0046 |
| 1 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 2 | Provitamin D2 Compound [EPC] | 57 | 0.0019 |
| 3 | Contrast Agent for Ultrasound Imaging [EPC] | 6 | 0.0010 |
| 4 | Adenosine Receptor Agonist [EPC] | 7 | 0.0009 |
| 5 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 7 | Parenteral Iron Replacement [EPC] | 5 | 0.0004 |
| 8 | Thymic Stromal Lymphopoietin Blocker [EPC] | 2 | 0.0003 |
| 9 | Dopamine-2 Receptor Antagonist [EPC] | 2 | 0.0003 |